Q4 2025 Pediatrix Medical Group Inc Earnings Call Transcript
Key Points
- Pediatrix Medical Group Inc (MD) reported a strong adjusted EBITDA of $66 million for Q4 2025, aligning with their upwardly adjusted guidance.
- The company achieved a full-year adjusted EBITDA of $276 million, reflecting strong financial control and strategic investments.
- Pediatrix Medical Group Inc (MD) introduced new programs to align physicians with company goals, involving over 500 physicians in stock price tracking bonuses.
- The company has a strong balance sheet with $375 million in cash and net debt of just over $220 million, reflecting net leverage of just under 1 time.
- Pediatrix Medical Group Inc (MD) is exploring growth opportunities in telemedicine and expanding its presence in NICUs and maternal fetal medicine, leveraging its established hospital relations.
- Consolidated revenue decreased due to net non-same unit activity of $26 million, driven by portfolio restructuring.
- Overall patient service volumes declined by just under 3%, with NICU days down about 2%.
- G&A expenses increased year over year due to modest salary and travel expense increases.
- Operating cash flow decreased to $115 million in Q4 2025 from $135 million in the prior year, primarily due to decreases in cash flow from accounts payable and accrued liabilities.
- The company faces uncertainty regarding the impact of ACA subsidies lapsing, which could affect future financial results.
Hello and thank you for standing by. At this time, I would like to welcome everyone to the Q4 2025 Pediatrics Medical Group Inc. Earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session.
If you would like to ask a question during this time, simply press star, followed by the number one on your telephone keypad. If you would like to withdraw your question again, press the one. I would now like to turn this conference over to Marianne Moore, Chief Administrative Officer and general counsel. You may begin.
Thank you, operator, and good morning. Certain statements and information during this call may be deemed to be forward-looking statements within the meeting of the Federal Private Securities Litigation Reform Act of 1,995. These forward-looking statements are based on assumptions and assessments made by pediatrics management in light of their
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
